Clinical Trial Update: Evaluation of the Effect of Intravitreal Injections of Anti-VEGF on Macular Perfusion in Diabetic Patients Using OCTA [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating the effect of intravitreal anti-VEGF injections on macular perfusion in diabetic patients using OCTA, with completed results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Macular Edema
• Ischemic Maculopathy

Snippet

Sponsor: Cairo University | Conditions: Diabetic Macular Edema, Ischemic Maculopathy | Phase 4 | Status: COMPLETED | Results posted: 2020-01-30